Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma

被引：0
|
作者：
Chun-Kuang Tsai
Chiu-Mei Yeh
Te-Lin Hsu
Chia-Ju Li
Chian Tin
Liang-Tsai Hsiao
Yao-Chung Liu
Hao-Yuan Wang
Po-Shen Ko
Po-Min Chen
Jin-Hwang Liu
Jyh-Pyng Gau
Chia-Jen Liu
机构：
[1] Taipei Veterans General Hospital,Division of Hematology, Department of Medicine
[2] National Yang-Ming University,Institute of Public Health
[3] Taipei Veterans General Hospital,Department of Medicine
[4] National Yang-Ming University,School of Medicine
[5] Cheng Hsin General Hospital,Division of Hematology and Oncology
[6] National Yang-Ming University,Chong Hin Loon Cancer and Biotherapy Research Center, and Institute of Biopharmaceutical Sciences
来源：
Supportive Care in Cancer | 2021年 / 29卷
关键词：
Multiple myeloma; Underweight; Hypoalbuminemia; Performance status; Lactate dehydrogenase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3991 / 3999
页数：8
相关论文
共 50 条
  • [31] Treatment for patients with newly diagnosed multiple myeloma in 2015
    Mateos, Maria-Victoria
    Ocio, Enrique M.
    Paiva, Bruno
    Rosinol, Laura
    Martinez-Lopez, Joaquin
    Blade, Joan
    Lahuerta, Juan-Jose
    Garcia-Sanz, Ramon
    San Miguel, Jesus F.
    BLOOD REVIEWS, 2015, 29 (06) : 387 - 403
  • [32] Protein Z in patients with newly diagnosed multiple myeloma
    Oleksiuk, J.
    Luksza, E.
    Kloczko, J.
    Galar, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 793 - 793
  • [33] Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma (vol 94, pg e2305, 2015)
    Hsu, P.
    Lin, T-W
    Gau, J-P
    MEDICINE, 2016, 95 (06)
  • [34] Serum Growth Differentiation Factor 15 Levels in Newly Diagnosed Multiple Myeloma Patients
    Tarkun, Pinar
    Atesoglu, Elif Birtas
    Mehtap, Ozgur
    Musul, Mahmut Mert
    Hacihanefioglu, Abdullah
    ACTA HAEMATOLOGICA, 2014, 131 (03) : 173 - 178
  • [35] Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma
    Geng, Chuanying
    Yang, Guangzhong
    Zhou, Huixing
    Wang, Huijuan
    Li, Yanchen
    Leng, Yun
    Zhang, Zhiyao
    Jian, Yuan
    Chen, Wenming
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):
  • [36] Deep and partial immunoparesis is a poor prognostic factor for newly diagnosed multiple myeloma patients
    Geng, Chuanying
    Yang, Guangzhong
    Wang, Huijuan
    Wu, Yin
    Leng, Yun
    Zhou, Huixing
    Zhang, Zhiyao
    Jian, Yuan
    Chen, Wenming
    LEUKEMIA & LYMPHOMA, 2021, 62 (04) : 883 - 890
  • [37] Early Mortality in Newly Diagnosed Multiple Myeloma in the Context of Novel Drugs
    O'Donnell, Elizabeth K.
    Kabrt, Jessica
    Ezenwajiaku, Nkiruka
    Yee, Andrew J.
    Horick, Nora
    Raje, Noopur S.
    BLOOD, 2015, 126 (23)
  • [38] Update on risk stratification and treatment of newly diagnosed multiple myeloma
    Prashant Kapoor
    S. Vincent Rajkumar
    International Journal of Hematology, 2011, 94 : 310 - 320
  • [39] Management of Newly Diagnosed Multiple Myeloma Based on Risk Stratification
    Callander, Natalie S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 : 17 - 19
  • [40] Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma
    Mellors, Patrick
    Binder, Moritz
    Ketterling, Rhett P.
    Griepp, Patricia
    Baughn, Linda B.
    Buadi, Francis K.
    Lacy, Martha Q.
    Gertz, Morie A.
    Dispenzieri, Angela
    Haymann, Suzanne
    Kapoor, Prashant
    Gonsalves, Wilson I.
    Hwa, Yi Lisa
    Fonder, Amie
    Hobbs, Miriam A.
    Kourelis, Taxiarchis
    Warsame, Rahma M.
    Lust, John A.
    Leung, Nelson
    Go, Ronald S.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    BLOOD, 2019, 134
12345